Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6608 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2009-09-17 (genengnews.com)
Biogen Idec and Facet—Following the Money
Biogen is trying to secure its multiple sclerosis (MS) franchise and is thus trying to acquire Facet in an attempt to gain full control over daclizumab.
Read more